MPG.eBooks - Staff View: CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events

Read Now

Bibliographic Details
Corporate Authors:	CADTH Canadian Drug Expert Committee, Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health May 25, 2017, 2017
Series:	CADTH common drug review
Subjects:	Venous Thrombosis / Drug Therapy Pulmonary Embolism / Drug Therapy Factor Xa Inhibitors / Therapeutic Use Pyridines / Therapeutic Use Thiazoles / Therapeutic Use
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK534995
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa


LEADER	01180nam a2200277 u 4500
001	EB001872088
003	EBX01000000000000001035459
005	00000000000000.0
007	tu\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|\|
008	190824 r \|\|\| eng
245	0	0	\|a CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events \|h Elektronische Ressource
246	3	1	\|a Edoxaban
260			\|a Ottawa (ON) \|b Canadian Agency for Drugs and Technologies in Health \|c May 25, 2017, 2017
300			\|a 1 PDF file (6 pages)
653			\|a Venous Thrombosis / drug therapy
653			\|a Pulmonary Embolism / drug therapy
653			\|a Factor Xa Inhibitors / therapeutic use
653			\|a Pyridines / therapeutic use
653			\|a Thiazoles / therapeutic use
710	2		\|a CADTH Canadian Drug Expert Committee
710	2		\|a Canadian Agency for Drugs and Technologies in Health
041	0	7	\|a eng \|2 ISO 639-2
989			\|b NCBI \|a National Center for Biotechnology Information
490	0		\|a CADTH common drug review
856	4	0	\|u https://www.ncbi.nlm.nih.gov/books/NBK534995 \|3 Volltext \|n NLM Bookshelf Books \|3 Volltext
082	0		\|a 610